Priscilla Zawislak, IPEC-Americas Chair, presents an overview of the the organizations 2016 accomplishments.
IPEC-Americas has developed a position paper to help industry review and reflect on the real purpose and/or utility of excipient DMFs.
IPEC-Americas has revised the sequence of quarterly committee meetings at headquarters. Mark your calendars now!
IPEC-Americas launched its first three eLearning courses and they’re off to a great start. Check out the video preview!
On July 15, 2015, FDA held a public meeting to seek input on the reauthorization of the Prescription Drug User Fee Act (2002) (PDUFA). David R. Schoneker presented comments during the meeting.
IPEC-Americas submits comments on the reauthorization of the Generic Drug User Fee Amendments of 2012.
